Both in Biotechnology
Cabaletta Bio vs ProKidney
Over the past year CABA returned −16.8% and PROK returned −34.3%; their daily moves had a correlation of 0.31.
CABA −16.8% PROK −34.3%Growth of $1, one year, split-adjusted
| Metric | CABA | PROK |
|---|---|---|
| Price | $1.98 | $1.63 |
| Market cap | $335.7M | $340.6M |
| Today | −1.00% | +1.24% |
| 1 month | −36.5% | −10.9% |
| 6 months | −19.8% | +0.6% |
| Year to date | −9.6% | −27.2% |
| 1 year | −16.1% | −34.5% |
| Revenue growth (YoY) | — | −32.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −18948.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 416.3× |
| Net cash | $205.1M | $181.6M |
| Dividend yield | — | — |
| Volatility (60d) | 68.5% | 68.6% |
| Short % of float | 24.4% | 24.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).